President Donald Trump took to Twitter early Friday to announce that he and First Lady Melania Trump had both tested positive for COVID-19. He stated they will both begin their quarantine and recovery process immediately. 

The development comes days after he appeared at the first presidential debate with Democratic opponent Joe Biden in Ohio. 

The First Lady stated on Twitter, “We are feeling good & I have postponed all upcoming engagements. Please be sure you are staying safe & we will all get through this together.”

Friday afternoon, she updated her status once again on Twitter writing, “Thank you for the love you are sending our way. I have mild symptoms but overall feeling good. I am looking forward to a speedy recovery.”

The New York Times reported:

“It is not yet clear when and how Mr. Trump contracted the virus. The President and the first lady said they had both tested positive hours after one of his closest aides, Hope Hicks, also tested positive. Ms. Hicks received the diagnosis after she began experiencing symptoms on Wednesday while attending the President’s rally in Minnesota.”

In a memo issued to reporters around 1 a.m. ET, the President’s physician, Navy Cmdr. Dr. Sean Conley wrote:

I release the following information with the permission of President Donald J. Trump and First Lady Melania Trump.

This evening I received confirmation that both President Trump and First Lady Melania Trump have tested positive for the SARS-CoV-2 virus.

The President and First Lady are both well at this time, and they plan to remain at home within the White House during their convalescence.

The White House medical team and I will maintain a vigilant watch, and I appreciate the support provided by some of our country’s greatest medical professionals and institutions.

Rest assured, I expect the President to continue carrying out his duties without disruption while recovering, and I will keep you updated on any future developments.

The positive test now puts into question the nature of the remaining 32 days of the presidential campaign, including the remaining two presidential debates. The next one is scheduled for Oct. 15 in Miami.

On Monday, President Trump announced from the White House Rose Garden, “I’m pleased to report we’re announcing our plan to distribute 150 million Abbott point of care tests in the coming weeks.” The 150 million rapid tests are intended for “states and territories to support efforts to reopen their economies and schools” and “to protect vulnerable communities,” according to the President. 

The Guardian has reported, “The White House uses the Abbott ID Now test, which has been found to produce a significant percentage of false negatives.”

Will the President and First Lady seek further tests to rule out false positives? Have they done so already? 

Follow The HighWire on Twitter for future updates.

Derek Kramer

Other Headlines

Coronavirus

ICAN Releases Recordings of FDA’s Peter Marks; Vaccine Official Dismissed Vaccine Injuries

The Informed Consent Action Network (ICAN) and REACT 19 held a joint press conference today to reveal a trove of secret recordings and FOIA documents of Peter Marks, the former Director of the Center for Biologics Evaluation and Research. The press conference included ICAN Founder Del Bigtree, Attorney Aaron Siri, and REACT 19’s Brianne Dressen.Continue reading ICAN Releases Recordings of FDA’s Peter Marks; Vaccine Official Dismissed Vaccine Injuries

More news about Coronavirus

Health & Nutrition

American Children Face 80% Higher Death Risk Than Peers in Wealthy Nations, JAMA Study Finds

A new study in JAMA found that US infants under the age of 1 are 1.78 times more likely to die than OECD countries, which are high-income nations. In addition, the study authors found that children aged 1-19 are 1.8 times more likely to die than children in the other 18 countries. From 2011 toContinue reading American Children Face 80% Higher Death Risk Than Peers in Wealthy Nations, JAMA Study Finds

More news about Health & Nutrition

Vaccines

Moderna’s SpikeVax Gets Full FDA Approval for High-Risk Children Amid Lawsuit Over Vaccine Policy Shift

Moderna received full FDA approval for its COVID-19 mRNA vaccine, called SpikeVax, for use in children aged 6 months to 11 years who are considered high risk. Previously, this vaccine was only given an Emergency Use Authorization (EUA) for this age group. In May, the CDC announced a change in its COVID-19 vaccine policy, noContinue reading Moderna’s SpikeVax Gets Full FDA Approval for High-Risk Children Amid Lawsuit Over Vaccine Policy Shift

More news about Vaccines

Science & Tech

Coinbase CEO Brian Armstrong Eyes Embryo-Editing Startup

Coinbase CEO Brian Armstrong declared his interest in creating a startup to work on gene-editing embryos, a type of editing that people say will lead to the creation of “designer babies.” CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology has been used in the medical field to help with certain conditions, and recently, a babyContinue reading Coinbase CEO Brian Armstrong Eyes Embryo-Editing Startup

More news about Science & Tech

Environment

USDA to Build Sterile Fly Factory to Stop Flesh-Eating Maggots from Invading U.S.

The USDA is going to breed millions of flies, sterilize them with radiation, and send them into Texas and Mexico to prevent a re-emergence of the New World Screwworm(NWS), also known as a flesh-eating maggot. The NWS is endemic to Cuba, the Dominican Republic, and some South American countries, but it was eradicated in theContinue reading USDA to Build Sterile Fly Factory to Stop Flesh-Eating Maggots from Invading U.S.

More news about Environment

Policy

Moderna’s SpikeVax Gets Full FDA Approval for High-Risk Children Amid Lawsuit Over Vaccine Policy Shift

Moderna received full FDA approval for its COVID-19 mRNA vaccine, called SpikeVax, for use in children aged 6 months to 11 years who are considered high risk. Previously, this vaccine was only given an Emergency Use Authorization (EUA) for this age group. In May, the CDC announced a change in its COVID-19 vaccine policy, noContinue reading Moderna’s SpikeVax Gets Full FDA Approval for High-Risk Children Amid Lawsuit Over Vaccine Policy Shift

More news about Policy